Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-I.
Liu X, Zhang Z, Aguirre T, Shipton ML, Fu L, Du J, Furkert D, Qi J, Chin AC, Riley AM, Liu T, Zhang X, Potter BVL, Fiedler D, Zhu Y, Fu C.
Liu X, et al. Among authors: chin ac.
Metabolism. 2025 Feb;163:156098. doi: 10.1016/j.metabol.2024.156098. Epub 2024 Dec 4.
Metabolism. 2025.
PMID: 39643078
Free PMC article.